Calidi Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -423 | -427 | -407 | -394 |
EBITDA | -4,043 | -4,703 | -5,298 | -4,593 |
EBIT | -4,466 | -5,130 | -5,705 | -4,987 |
Net Income | -4,056 | -5,149 | -5,715 | -4,986 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,073 | -4,265 | -4,937 | -7,138 |
Cash | 5,600 | 10,375 | 5,279 | 10,561 |
Basic Shares | 7,216 | 4,907 | 2,877 | 2,248 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $45 |
Gross Profit | -1,651 | -1,535 | -1,256 | -229 |
EBITDA | -20,240 | -19,727 | -24,195 | -24,998 |
EBIT | -21,891 | -21,262 | -25,451 | -25,258 |
Net Income | -25,579 | -22,143 | -29,216 | -25,427 |
Net Change In Cash | 0 | 0 | 0 | 45 |
Free Cash Flow | -21,293 | -19,710 | -27,568 | -13,642 |
Cash | 5,600 | 9,591 | 2,049 | 372 |
Basic Shares | 4,302 | 664 | 140 | 70 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.21 |
2025-06-30 | -$1.99 |
2025-03-31 | -$0.18 |
2024-12-31 | -$0.27 |
